Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Pulmonary Hypertension peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Pulmonary Hypertension. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
2 profiles.
2015–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 55 selected PubMed records and 15 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Pulmonary Hypertension unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00205426
PeptideScanner retained ClinicalTrials.gov record NCT00205426 at 2026-11-16T01:39:41.882Z. Its registry update date was 2015-10-14, and PeptideScanner's reviewed identity mapping was nesiritide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 14, 2015
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07614438
PeptideScanner retained ClinicalTrials.gov record NCT07614438 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-06-02, and PeptideScanner's reviewed identity mapping was vasopressin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 2, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Vasopressin · 2026-06-02
ClinicalTrials.gov record NCT07614438
Not yet recruiting at the retained observation.
Open attributed record →Nesiritide · 2015-10-14
ClinicalTrials.gov record NCT00205426
Completed at the retained observation.
Open attributed record →